Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Denosumab/risedronic acid/zoledronic acid

Osteonecrosis of jaw: 28 case reports

    This is a preview of subscription content, log in to check access.

    Reference

    1. Chaurand-Lara J, et al. Incidence of osteonecrosis of the jaw by the use of osteoclast inhibitors in patients with bone metastases: a retrospective cohort study. Cirugia y Cirujanos 87: 396-401, No. 4, 2019. Available from: URL: http://doi.org/10.24875/CIRU.18000661 [Spanish; summarised from a translation]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Denosumab/risedronic acid/zoledronic acid. Reactions Weekly 1791, 93 (2020). https://doi.org/10.1007/s40278-020-74938-5

    Download citation